Victoria Anne Gordon

This inventor holds 18 USPTO granted patents and 4 published patent applications, plus 7 CIPO patents and 6 EPO patents, primarily in Oncology Research. Top assignees: Qbiotics Pty Ltd, Ecobiotics Ltd, Qbiotics Limited. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria Anne Gordon. Retrieved from https://idiyas.com/inventor/victoria-anne-gordon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 4)

% Patents Active = 94.4

CIPO Patents = 7

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 23(Granted Patents)

Company Filing History:

Johnson & Johnson Consumer Inc.

patents

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Biofilm Disruption

Tumor Treatment

Tiglien-3-One Derivatives

Combination Therapy

Wound Healing

Skin Lightening

Spiroketals

Compositions

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12514843 - Biofilm disruption (2026-01-06),

2. 12226391 - Method of treating tumours (2025-02-18),

3. 12208078 - Tiglien-3-one derivatives (2025-01-28),

4. 11213506 - Combination therapy for the treatment or prevention of tumours (2022-01-04),

5. 10980769 - Tiglien-3-one derivatives (2021-04-20),

6. 10822317 - Methods and compositions for wound healing (2020-11-03),

7. 10543188 - Tiglien-3-one derivatives (2020-01-28),

8. 10183922 - Methods and compositions for wound healing (2019-01-22),

9. 10183921 - Methods and compositions for wound healing (2019-01-22),

10. 9814659 - Methods of lightening the skin (2017-11-14),

11. 9770431 - Tiglien-3-one derivatives (2017-09-26),

12. 9289410 - Tiglien-3-one derivatives (2016-03-22),

13. 9220928 - [object Object] (2015-12-29),

14. 8921414 - Spiroketals (2014-12-30),

15. 8680141 - Spiroketals (2014-03-25),

Title: Victoria Anne Gordon: Innovator in Cancer Treatment and Infection Control

Introduction

Victoria Anne Gordon is a prominent inventor based in Yungaburra, Australia. She has made significant contributions to the fields of cancer treatment and infection control, holding a total of 18 patents. Her innovative approaches have the potential to change the landscape of medical treatments.

Latest Patents

Among her latest patents is a method of treating tumours, which involves the localized administration of an epoxytiglienone compound. This method aims to generate a systemic anticancer abscopal and/or bystander effect when applied to cancerous tumours. Another notable patent involves tiglien-3-one derivatives, which are used in treating or preventing protozoal infections, bacterial infections, parasitic infections, and cell proliferative disorders. These compounds also have applications in pest control for humans, animals, plants, and the environment.

Career Highlights

Victoria has worked with several companies, including Qbiotics Pty Ltd and Ecobiotics Ltd. Her work in these organizations has been instrumental in advancing research and development in her areas of expertise.

Collaborations

Some of her notable coworkers include Paul Warren Reddell and Glen Mathew Boyle. Their collaborative efforts have contributed to the success of her innovative projects.

Conclusion

Victoria Anne Gordon is a trailblazer in the field of medical innovation, with a focus on cancer treatment and infection control. Her patents and collaborations reflect her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.